Repligen (RGEN) EPS (Weighted Average and Diluted) (2010 - 2026)
Repligen (RGEN) reported EPS (Weighted Average and Diluted) of $0.15 for Q1 2026, up 50.0% year-over-year from $0.1 in Q1 2025, and down 34.78% quarter-over-quarter from $0.23 in Q4 2025.
Repligen (RGEN) EPS (Weighted Average and Diluted) (2010 - 2026) Analysis & Trends
Repligen (RGEN) has 17 years of EPS (Weighted Average and Diluted) data on file, last reported at $0.15 in Q1 2026.
- EPS (Weighted Average and Diluted) for Q1 2026 came in at $0.15, up 50.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $0.9 (up 314.29% YoY), and the FY2025 annual result was $0.86, up 286.96% from the prior year.
- EPS (Weighted Average and Diluted) declined to $0.15 in Q1 2026 per RGEN's latest filing, from $0.23 in the prior quarter.
- Over five years, EPS (Weighted Average and Diluted) peaked at $0.88 in Q2 2022 and troughed at -$0.61 in Q4 2024.
- A 5-year average of $0.26 and a median of $0.26 in 2025 frame the typical range for EPS (Weighted Average and Diluted).
- The sharpest annual moves came in 2023 and 2025: EPS (Weighted Average and Diluted) sank 132.94% in 2023, then jumped 2700.0% in 2025.
- A 5-year view of EPS (Weighted Average and Diluted) shows it stood at $0.85 in 2022, then slumped by 132.94% to -$0.28 in 2023, then slumped by 117.86% to -$0.61 in 2024, then jumped by 137.7% to $0.23 in 2025, then tumbled by 34.78% to $0.15 in 2026.
- Business Quant data shows RGEN's EPS (Weighted Average and Diluted) at $0.15 in Q1 2026, $0.23 in Q4 2025, and $0.26 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 2.28 |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -1.11 |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 0.16 |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 2.74 |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 1.92 |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 0.07 |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -0.40 |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 1.57 |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -0.03 |
| 10 | Repligen | 7.41 Bn | 6.42 Bn | 108.28 Mn | 0.15 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.15 |
| Dec 31, 2025 | 0.23 |
| Sep 30, 2025 | 0.26 |
| Jun 30, 2025 | 0.26 |
| Mar 31, 2025 | 0.10 |
| Dec 31, 2024 | -0.61 |
| Sep 30, 2024 | -0.01 |
| Jun 30, 2024 | 0.10 |
| Mar 31, 2024 | 0.06 |
| Dec 31, 2023 | -0.28 |
| Sep 30, 2023 | 0.30 |
| Jun 30, 2023 | 0.35 |
| Mar 31, 2023 | 0.27 |
| Dec 31, 2022 | 0.85 |
| Sep 30, 2022 | 0.71 |
| Jun 30, 2022 | 0.88 |
| Mar 31, 2022 | 0.81 |
| Dec 31, 2021 | 0.50 |
| Sep 30, 2021 | 0.58 |
| Jun 30, 2021 | 0.64 |